Organogenesis Holdings (ORGO) Asset Utilization Ratio (2017 - 2026)

Organogenesis Holdings' Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.92 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 3.19% year-over-year to 0.92; the TTM figure through Mar 2026 stood at 0.92 (down 3.19% YoY), while the FY2025 annual figure was 1.03, up 2.23% from the prior year.
• Asset Utilization Ratio was 0.92 for Q1 2026 at Organogenesis Holdings, down from 1.02 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.05 in Q1 2022 to a low of 0.92 in Q1 2026.
• Historically, Asset Utilization Ratio has averaged 0.99 across 5 years, with a median of 0.99 in 2022.
• The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio declined 19.74% in 2022, then grew 8.75% in 2024.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.99 in 2022, then decreased by 5.61% to 0.94 in 2023, then gained by 8.75% to 1.02 in 2024, then retreated by 0.32% to 1.02 in 2025, then decreased by 9.6% to 0.92 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.92 (Q1 2026), 1.02 (Q4 2025), and 0.96 (Q3 2025), per Business Quant data.